Commit Biologics
Commit Biologics is potently directed to kill tumor cells using b-specific domain antibodies and further refined into the modular technology that can be formatted to target and destroy cancer cells by engaging the body's innate immune response, enabling healthcare professionals to activate the complement component of the immune system to treat cancer and autoimmune diseases.
$17.25M
Latest Funding
Seed
Latest Funding Stage
2024-05-09
Funding Date
18
Employees
Denmark
Location
Aarhus, Midtjylland
City & State
Sales-Ready Summary
Commit Bio recently raised $17.25M in Seed funding and is hiring for Bioinformatics and Engineering roles, suggesting they are expanding their team and infrastructure.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.